Member Info for AgentB

Mr R do you work in the Gov statistics department or the MSM? Can you not see the blindingly obvious rises (c24%) in both NCYT and GDR today on news of this new variant?

A quick look at “Covid test stocks” today suggests anticipation of a pivot back to (govt manipulated) PCR testing. Warning our MPs that LFTs need further CV to check for new variant will likely backfire and they will just opt for Lockdown and PCR.

WHO special session begins Monday. Looks like this will ultimately take pandemic response protocol out of the control of individual governments.
https://www.who.int/news-room/events/detail/2021/11/29/default-calendar/second-special-session-of-the-world-health-assembly

Prof, I think you have the address slightly wrong. It’s FTI, not FTSI
Avacta.LS@fticonsulting.com
However, I have also emailed them several times and never had a reply.

Probably explains why Pfizer share price is up nearly 6% pre-market.

Surely all currently commercialised LFTs should also undergo CV for effectiveness against the new variant.

By the way, he also says that VitaminD improves vaccine efficiency, so it's not an antivax message!

MrA - just for you the original academic paper from Germany that supports the claim that
COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status
https://www.mdpi.com/2072-6643/13/10/3596/htm
@Uptomyneck If you watch the video from about 12 mins he discusses Vitamin D interaction with calcium levels from 14 mins he gives recommended dosages of Vitamin D (100-200 micrograms per day) and at 15 mins recommendations for K2 which cancels out any potential negative effects of higher vitamin D dosage.)

Could somebody who isn’t banned by the McNumpty congregation please copy and paste this message for those who just see a green box? Many thanks.

I note that MHC is still going strong on the back of its day 2 home use with Flowflex news. How does anyone know whether Flowflex captures the nu variant? I expect there will be a reversion to PCR a testing for inbound travellers.

For those who are very concerned about the new variant, please be aware that there is a proven relationship between high levels of vitamin D in the system and better Covid outcomes.
However, it is worth noting that the daily recommended dose of vitamin D shown on most supplement containers was developed in response to the fight against rickets several decades ago. The recommended intake to improve immunity against Covid is 100mg per day, accompanied by vitamin K which helps to ensure that it goes into bloodstream rather than bones.

As the Government continues to fail abjectly in its public health messaging, please pass this information on to all your loved ones.
A fascinating video here explains the science
https://youtu.be/V5g9AVqRsjo

My point is that a few weeks ago,the possibility of Avacta getting FDA HUA for AffiDX was being ramped against the backdrop of severe shortages of LFTs Stateside. I thought we stood no chance because of ODX’s prior submission on behalf of Mologic. It now appears that this never happened.

It’s definitely at odds with this from 2nd July:

“ Omega Diagnostics (ODX) said a submission has been filed to the US FDA requesting Emergency Use Authorization (EUA) for its rapid point-of-care COVID-19 antigen test for use under both the Omega's VISITECT® brand and Global Access Diagnostics (GAD) brand. ”

TBH Timster, I found that statement v surprising. Thought the Great Philanthropist was pulling the strings behind the scenes and all.

Feel extremely glad to have sold by small ODX holding yesterday on the basis of long term holders’ predictions about likely carnage today. If they didn’t also sell, it just shows the dangers of ‘falling in love with a stock’.

Interesting detail in their RNS is this: “ A feasibility study as to the process, timelines and likely high-level costs associated with the submission of the VISITECT® COVID self-test for FDA approval is currently underway, although the cost of gaining approval may be prohibitive.”

Suggesting that they are not, after all pursuing home use in the USA.

Not sure what goes on in Germany, but Medco Solutions probably slipped DHSC an brown envelope to get the NHS gig using Flowflex.
https://bidstats.uk/tenders/2021/W37/758972796

It’s not MHC that got the HUA, but Flowflex, the latest Chinese test to benefit from the brown envelope culture.

I like it on a blue day!

Boris wants out. A bad sign.

Using Flowflex.
https://www.lse.co.uk/rns/MHC/launch-of-covid-19-rapid-antigen-test-service-83iu53nfy2qo907.html